
Optimizing chemotherapy for transitional cell carcinoma by application of bcl-2 and bcl-xL antisense oligodeoxynucleotides
Keywords: Bladder neoplasms; Transitional cell carcinoma; Chemotherapy; Antisense oligodeoxyribonucleotides; Antineoplastic combined chemotherapy protocols